HYDRAFIL System
Chronic low back pain due to degenerative disc disease (DDD)
Key Facts
About ReGelTec
ReGelTec is pioneering a next-generation, minimally invasive solution for the massive problem of degenerative disc disease (DDD). Its lead product, the HYDRAFIL System, is a proprietary hydrogel that is injected as a liquid through a needle and solidifies in the disc nucleus to mimic natural biomechanics. The company has achieved significant milestones, including CE Mark approval in Europe and the initiation of a pivotal FDA IDE study in the US, supported by strong 1- and 2-year clinical data showing significant reductions in pain and disability. With an experienced leadership team and a technology that addresses a key unmet need between conservative care and major surgery, ReGelTec is positioned as a compelling player in the spinal intervention market.
View full company profile